ERBB2 and breast cancer: Carotenoid-enriched fractions from S. mombin inhibit the ATP kinase domain of HER2 in silico studies and validated via in vivo studies by downregulating HER2 mRNA expression and upregulating p53 and p27 mRNA expression in the HER2+ model of breast cancer.